Cite
Dynamics of Melanoma-Associated Epitope-Specific CD8+ T Cells in the Blood Correlate With Clinical Outcome Under PD-1 Blockade.
MLA
Gaißler, Andrea, et al. “Dynamics of Melanoma-Associated Epitope-Specific CD8+ T Cells in the Blood Correlate With Clinical Outcome Under PD-1 Blockade.” Frontiers in Immunology, vol. 13, July 2022, pp. 1–12. EBSCOhost, https://doi.org/10.3389/fimmu.2022.906352.
APA
Gaißler, A., Meldgaard, T. S., Heeke, C., Babaei, S., Tvingsholm, S. A., Bochem, J., Spreuer, J., Amaral, T., Wagner, N. B., Klein, R., Meier, F., Garbe, C., Eigentler, T. K., Pawelec, G., Claassen, M., Weide, B., Hadrup, S. R., & Wistuba-Hamprecht, K. (2022). Dynamics of Melanoma-Associated Epitope-Specific CD8+ T Cells in the Blood Correlate With Clinical Outcome Under PD-1 Blockade. Frontiers in Immunology, 13, 1–12. https://doi.org/10.3389/fimmu.2022.906352
Chicago
Gaißler, Andrea, Trine Sundebo Meldgaard, Christina Heeke, Sepideh Babaei, Siri Amanda Tvingsholm, Jonas Bochem, Janine Spreuer, et al. 2022. “Dynamics of Melanoma-Associated Epitope-Specific CD8+ T Cells in the Blood Correlate With Clinical Outcome Under PD-1 Blockade.” Frontiers in Immunology 13 (July): 1–12. doi:10.3389/fimmu.2022.906352.